Enlivex Analyst Price Targets - Benzinga

Enlivex Ltd

ENLVNASDAQ

Trade with Public

Trade with Public

$1.78

-0.76-29.92%

마지막 업데이트: Oct 30, 7:17 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Enlivex Analyst Price Targets

Wall Street analyst price targets and consensus rating for Enlivex (ENLV).

Price Target Range — 10 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$2200Upside to Avg. PT+122805.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$320→$1280
Apr 7, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$3120→$4800
Jan 12, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$1680→$3120
Nov 24, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Oct 29, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Sep 26, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Sep 12, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Sep 2, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$1680
Aug 22, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Aug 18, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Jul 29, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Jul 22, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Apr 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Apr 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Mar 24, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$1440→$1680
Mar 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Feb 7, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Dec 11, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Dec 3, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120
Nov 14, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$3120

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $80

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $20 to $80.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $20

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $13 to $20.

Benzinga Newsdesk

Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum

Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing prediction markets and token burn mechanics.

Vandana Singh

PRO
HC Wainwright & Co. Maintains Buy on Enlivex Therapeutics, Raises Price Target to $13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and raises the price target from $7 to $13.

Benzinga Newsdesk

PRO
D. Boral Capital Downgrades Enlivex Therapeutics to Hold

D. Boral Capital analyst Jason Kolbert downgrades Enlivex Therapeutics (NASDAQ:ENLV) from Buy to Hold.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target

D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and maintains $13 price target.

Benzinga Newsdesk